NT
Novotech (Australia) Pty Ltd
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79325918 |
| Mark Drawing Code | 3000: Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) |
Timeline
| 2021-10-15 | Application Filed |
| 2021-11-18 | Location: INITIAL REVIEW/SERIALIZATION BRANCH(MAILROOM) |
| 2021-11-18 | Status: Live/Pending |
| 2021-11-19 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Novotech (Australia) Pty Ltd |
| Entity Statement | A company legally organised under the laws of Australia |
| Address | L 3 235 Pyrmont St Pyrmont NSW 2009 AU |
| Legal Entity Type | |
| Legal Entity State | AU |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Design Search Codes
| 260921 | Squares that are completely or partially shaded |
Attorney of Record
Good, Services, and Codes
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0421 | Clinical trials; conducting and managing clinical trials, including clinical trials for pharmaceuticals, biotechnology and other related industries; conducting clinical trials for others (scientific research); providing information about the results of clinical trials, including clinical trials for pharmaceuticals and biotechnology; scientific research; medical research (scientific research for medical purposes); preparation of statistics for scientific research; preparation of biostatistics for scientific research in the fields of pharmaceuticals, biotechnology and other related industries; provision of information and data relating to medical and scientific research for pharmaceuticals, biotechnology and other related industries; database design and development services to process data collected from clinical trials; medical research services, namely, medical monitoring services for research in the fields of pharmaceuticals, biotechnology and other related industries; quality audits; preparation of reports and applications to regulators relating to aspects of clinical trials; provision and exchange of information and data exchange between scientists, manufacturers and health authorities relating to pharmaceutical and biotechnology quality standards; technical writing of clinical report forms which are required by clinical trial drug protocols |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2021-11-18 | 1 REPR M: |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2021-11-19 | 2 NWOS I:Incoming Correspondence |
| APPLICATION FILING RECEIPT MAILED | 2021-11-23 | 3 MAFR O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2022-07-22 | 4 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2022-07-26 | 5 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2022-07-27 | 6 RFCR E:E-Mail |
| REFUSAL PROCESSED BY MPU | 2022-08-19 | 7 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2022-08-19 | 8 RFCS P: |
| REFUSAL PROCESSED BY IB | 2022-09-12 | 9 RFNT P: |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2022-10-17 | 10 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2022-10-17 | 11 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2022-10-18 | 12 TEME I:Incoming Correspondence |
| SUSPENSION LETTER WRITTEN | 2022-10-20 | 13 CNSL R:Renewal |
| LETTER OF SUSPENSION E-MAILED | 2022-10-20 | 14 GNSL S: |
| NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2022-10-20 | 15 GNS3 O:Outgoing Correspondence |
| NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | 2023-04-19 | 16 OPNR P: |
| REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | 2023-04-19 | 17 RCSC S: |
| NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2023-04-19 | 18 OPNS P: |
| NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | 2023-05-09 | 19 OPNX P: |
| REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | 2023-10-17 | 20 RCSC S: |
| SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | 2024-04-17 | 21 RCCK S: |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2024-05-02 | 22 CNSA O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2024-05-15 | 23 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2024-06-04 | 24 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2024-06-04 | 25 NPUB E:E-Mail |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 